Paola Valsasina1, Milagros Hidalgo de la Cruz1, Francesca Sangalli2, Federica Esposito2, Massimo Filippi1,2,3, and Maria A. Rocca1,2
1Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy, 2Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy, 3Vita-Salute San Raffaele University, Milan, Italy
Synopsis
In this study, we used dynamic
functional connectivity (dFC) to characterize time-varying connectivity
abnormalities in patients with multiple sclerosis (MS) with the main disease
phenotypes. Compared to controls, MS patients presented overall dFC reduction in all networks,
along with increased dFC in sensorimotor, default-mode and frontal/attention
networks. While progressive MS showed additional dFC decrease vs relapsing-remitting (RR) MS, in
benign MS the overall reduction of dFC was accompanied by significantly
increased dFC in the sensorimotor, default-mode and frontal/attention networks.
Reduced dFC
correlated with more severe clinical disability and worse cognitive performance.
Introduction
Dynamic functional
connectivity (dFC) is a novel analysis technique that measures temporal resting state (RS) functional connectivity
(FC) fluctuations occurring during the course of functional MRI (fMRI)
acquisition [1]. To date, RS dFC has
been widely applied to neurodegenerative and psychiatric conditions [2], but a
comprehensive description of RS dFC abnormalities across the different stages
of multiple sclerosis (MS) has not been performed. Aim of this study was to
investigate RS dFC abnormalities in the main clinical phenotypes of MS.Methods
RS
fMRI data were acquired from 128 MS patients (53 relapsing remitting [RR] MS,
16 benign [B] MS, 34 secondary progressive [SP] MS, 25 primary progressive [PP]
MS), and 40 healthy controls (HC). Forty-two relevant independent
components were identified and assigned to sensorimotor, default-mode,
frontal/attention, salience, executive, visual, temporal/auditory, and
cerebellar networks (Figure 1). dFC properties were assessed using sliding
windows correlations and grouping FC matrices into recurrent states (hard-clustering
analysis) [3]. Between-group dFC differences and correlations between dFC abnormalities
and motor and cognitive performances were assessed.Results
Hard-clustering analysis revealed 3 dFC states in HC and MS patients: State 1
(frequency=57%, low dFC strength), State 2 (frequency=19%, middle-high dFC
strength), and State 3 (frequency=24%, high dFC strength within sensorimotor
and visual networks) (Figure 2). MS patients showed overall dFC reduction in
all States vs HC, along with
increased dFC in sensorimotor and default-mode networks in State 2, and
increased dFC in the frontal/attention network in State 3 (Figure 3). Similar
findings were detected when comparing PPMS and RRMS patients vs HC, and SPMS vs RRMS patients (Figure 4). In BMS vs RRMS patients, the overall reduction of dFC was accompanied by
significantly increased dFC in the sensorimotor, default-mode and
frontal/attention networks in State 1 (Figure 5). In MS patients, reduced dFC
in State 1 and increased dFC in States 2 and 3 of sensorimotor, default-mode
and frontal/attention networks correlated with more severe motor disability and
worse cognitive impairment (r=range 0.19-0.31, p=range <0.001-0.05).Discussion
In this study, we described the existence of RS
dFC abnormalities that helped to characterize the different clinical phenotypes
of MS, while helping to explain more severe clinical disability, and worse
motor and cognitive performances. RS dFC approach may contribute to identify brain
areas in which neuroprotection/neurorehabilitation therapies might be applied,
mainly in the progressive phase of the disease. Conclusions
Significant
dFC abnormalities, mainly in sensorimotor and cognitive networks, contributed to explain MS phenotypic
heterogeneity, clinical disability and cognitive impairment, suggesting the presence of
maladaptive responses in progressive MS patients and compensatory mechanisms in
BMS.Acknowledgements
Partially supported by Fondazione Italiana
Sclerosi Multipla (FISM2018/S/3).References
[1] Calhoun VD et
al,. Neuron 2014; 84: 262-74.
[2] Damaraju
E et al,. Neuroimage: clinical 2014;24: 298-308.
[3] Allen E et al,. Cereb Cortex 2014;24: 663-676.